CVS Group Regulatory News (CVSG)

31 March 2026

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that, as of 31 March 2026, the Company's total issued share capital consists of 70,156,883 ordinary shares of 0.2p each ("Ordinary Shares") with each one carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 70,156,883.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc via Camarco

Scott Morrison, General Counsel and Company Secretary

Camarco (Financial PR)

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 About CVS Group plc (www.cvsukltd.co.uk)

CVS is a leading provider of veterinary services, operating in the UK and Australia and listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates c.475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an Online Retail Business ("Animed Direct").

The Group employs c.9,000 personnel, including c.2,500 veterinary surgeons and c.3,300 nurses and patient care assistants.